Recruiting Ankylosing Spondylitis Studies in Hamburg
ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
The purpose of this study (Study INZ701-304 \[ADAPT\]) is to assess the long-term safety of INZ-701 in patients with ENPP1 Deficiency or ABCC6 Deficiency who have received INZ-701 in an existing clini...
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
DEMETHER is a phase II trial exploring the maintenance of trastuzumab and pertuzumab fixed dose combination (FDC) for subcutaneous administration (SC, PHESGO) following trastuzumab deruxtecan (T-DXd) ...
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
Children and adults diagnosed with high-risk neuroblastoma patients with primary refractory disease or incomplete response to salvage treatment in bone and/or bone marrow will be treated for up to 101...
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis...
About Ankylosing Spondylitis Clinical Trials in Hamburg
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Hamburg, CITY%20STATE%20OF%20HAMBURG. These studies are seeking a combined 553 participants. Research is being sponsored by Inozyme Pharma, MedSIR, Y-mAbs Therapeutics and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Hamburg — FAQ
Are there ankylosing spondylitis clinical trials in Hamburg?
Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Hamburg, CITY%20STATE%20OF%20HAMBURG. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hamburg?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hamburg research site will contact you about next steps.
Are clinical trials in Hamburg free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hamburg studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 4 active trials in Hamburg are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov